Nalaganje...
Miliary Tuberculosis in a Crohn's Disease Patient: The Risk beyond the Screening
Tumor necrosis factor alpha (TNFα) antagonist is recognized as an effective treatment to achieve clinical remission and healing mucosal in patients with moderate to severe active Crohn's disease. Considering that it plays a central role in immune-mediated modulation, there are some obvious conc...
Shranjeno v:
| izdano v: | GE Port J Gastroenterol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
S. Karger AG
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6341350/ https://ncbi.nlm.nih.gov/pubmed/30675506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000487297 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|